REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)

50 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share as of Q1 2024.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5.57M shares of 101M outstanding shares and own 5.5% of the company stock.
Largest 10 shareholders include Woodline Partners LP (1.06M shares), VANGUARD GROUP INC (1M shares), MILLENNIUM MANAGEMENT LLC (855K shares), Schonfeld Strategic Advisors LLC (827K shares), Parkman Healthcare Partners LLC (504K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (243K shares), GEODE CAPITAL MANAGEMENT, LLC (220K shares), Colony Group, LLC (171K shares), Polar Asset Management Partners Inc. (155K shares), and EMC Capital Management (124K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.